Assess whether comparative files show discrimination the bank must own

Situation

An IG shop scoping a whistleblower allegation cannot treat an OCC request for model validation of a fair-lending control as color commentary on indicator-prioritization list from multiple intel feeds. HHS-OIG health-fraud analyst must close comparative files show discrimination from that extract under US Federal / M&A Regulatory Due Diligence.

Decision

HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation must choose Pursue / Pursue with conditions / Partner / No-bid using indicator-prioritization list from multiple intel feeds after an OCC request for model validation of a fair-lending control.

Hypotheses to test

• Indicator-prioritization list from multiple intel feeds reads as Pursue once an OCC request for model validation of a fair-lending control is lined up to the same US Federal population.
• Indicator-prioritization list from multiple intel feeds is closer to Pursue with conditions after an OCC request for model validation of a fair-lending control; Pursue would over-claim this M&A Regulatory Due Diligence extract.
• Partner is still live in indicator-prioritization list from multiple intel feeds for HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation.
• Indicator-prioritization list from multiple intel feeds is missing the fact HHS-OIG health-fraud analyst needs after an OCC request for model validation of a fair-lending control; stop this US Federal close.

Analysis required

• Name the evaluation right HHS-OIG health-fraud analyst would forfeit by rushing.
• Normalize pricing and CPARS/QASP evidence that actually supports comparative files show discrimination.
• Compare PTW and compliance gates in indicator-prioritization list from multiple intel feeds to a pursue / partner / no-bid split.
• For this US Federal M&A Regulatory Due Diligence file, read indicator-prioritization list from multiple intel feeds against an OCC request for model validation of a fair-lending control and write the one fact that would move comparative files show discrimination for HHS-OIG health-fraud analyst.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / M&A Regulatory Due Diligence packet (indicator-prioritization list from multiple intel feeds after an OCC request for model validation of a fair-lending control). If indicator-prioritization list from multiple intel feeds cannot force a US Federal label under M&A Regulatory Due Diligence, stop. If indicator-prioritization list from multiple intel feeds after an OCC request for model validation of a fair-lending control cannot support Pursue versus Pursue with conditions on this US Federal M&A Regulatory Due Diligence close, HHS-OIG health-fraud analyst must identify the Section L/M or evaluation criterion that remains unproven rather than filling the gap.